Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Pediatr Clin North Am. 2012 Aug 26;59(5):1205–1220. doi: 10.1016/j.pcl.2012.07.007

Table 2.

Overview of Proposed Changes to Federal Regulatory Framework for Human Subjects Protection

Ensuring risk-based protections
  • -

    Refinement of existing risk-based regulatory framework

  • -

    Calibration of the levels of review to the level of risk

  • -

    New mechanism for protecting subjects from informational risks

Streamlining IRB review of multi-site studies
  • -

    Utilization of single IRB review for domestic sites of multi-center studies

Improved informed consent
  • -

    Improved consent forms

  • -

    Waiver of informed consent or documentation of informed consent in primary data collection

  • -

    Strengthened consent protections related to reuse or additional analysis of existing data and biospecimens

Strengthening data protections to minimize information risks
  • -

    Consistent characterization of information with respect to potential for identification

  • -

    Standards for data security and information problems

Data collection to enhance system oversight
  • -

    Establishment of an improved, more systematic approach for the collection and analysis of data on unanticipated problems and adverse events

Extension of Federal regulations
  • -

    Regulatory protections to all research, regardless of funding source, conducted at U.S. institutions that receive Federal funding from a Common Rule agency for human subjects research

Consistency across Federal regulations
  • -

    Improvement in the harmonization of regulations and related agency guidance

Adapted from: Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators; Advance Notice of Proposed Rulemaking. Federal Register. July 26, 2011 2011;76(143):44512–44531